HIGHLIGHTS
- who: Jonathan R. Strosberg et al. from the Department University Medical Center, Rotterdam, The Netherlands have published the article: Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE, in the Journal: (JOURNAL) of June/30,/2016
- what: The authors report the impact of Lu-DOTATATE treatment on abdominal pain diarrhea and flushing symptoms that patients with advanced midgut neuroendocrine tumors often find burdensome.
- how: One difference between this study and the previously reported HRQoL analysis is that whereas the symptom diary analysis demonstrated a statistically significant symptom improvement in flushing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.